LENZ
Commercializes VIZZ, an FDA-approved aceclidine eye drop for adult presbyopia.
$4.72
After-hours close−0.40 (−7.77%)
At close$5.12(+6.44%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 111.29%Insiders 0.35%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 31.35M · Float 27.36M · 87.3% free float
Institutions13F, as of Jun 30, 2026
150 holders · 34.89M shares · 28 new positions · 89 increased · 35 reduced · 28 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 4.18M | 13.33% | 0 | Aug 14, 2026 |
| Alpha Wave Global, LP | 3.61M | 11.52% | 0 | Aug 13, 2026 |
| FMR LLC | 3.56M | 11.35% | −38.9K | Aug 13, 2026 |
| Versant Venture Management, LLC | 2.66M | 8.47% | 0 | Aug 12, 2026 |
| BlackRock, Inc. | 2.29M | 7.31% | +315.3K | Aug 7, 2026 |
| Squarepoint Ops LLC | 1.75M | 5.57% | +240.6K | Aug 14, 2026 |
| Abrdn PLC | 1.55M | 4.94% | +391.7K | Jul 31, 2026 |
| Millennium Management LLC | 1.51M | 4.81% | +639.2K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Rajeev Shahincl. RA Capital Healthcare Fund, L.P., Peter Kolchinsky +1 more | 13.60% | 4.27M | 13D | Nov 7, 2025 ↗ |
| FMR LLC | 11.80% | 3.70M | 13G | Feb 5, 2026 ↗ |
| BlackRock, Inc. | 5.80% | 1.80M | 13G | Apr 27, 2026 ↗ |
| Millennium Management LLC | 5.10% | 1.60M | 13G | Jun 26, 2026 ↗ |
| Squarepoint Ops LLC | 5.10% | 1.59M | 13G | Apr 8, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | 10 percent owner | 1.81M | 5.79% | Oct 2, 2025 |
| Evert B. Schimmelpennink | director, officer: President, CEO and Secretary | 77.3K | 0.25% | Mar 30, 2026 |
| Daniel R. Chevallard | officer: Chief Financial Officer | 12.9K | 0.04% | Mar 30, 2026 |
| James W. Mccollum | director | 10.5K | 0.03% | Nov 10, 2025 |
| Jeffrey P. George | director | 5.6K | 0.02% | Mar 30, 2026 |
| Shawn Olsson | officer: Chief Commercial Officer | 4.7K | 0.02% | Nov 19, 2025 |
3 ten-percent owners hold 7.03M shares by Form 4, outside the officers-and-directors figure above · 2 people have not refiled in the last 18 months (794.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 27, 2026 | Daniel R. Chevallardofficer: Chief Financial Officer | Purchase | 7,500 | $8.57 | 12,886 |
| Mar 27, 2026 | Evert B. Schimmelpenninkdirector, officer: President, CEO and Secretary | Purchase | 28,089 | $8.95 | 77,289 |
| Mar 27, 2026 | Jeffrey P. Georgedirector | Purchase | 5,592 | $8.92 | 5,592 |
| Nov 17, 2025 | Shawn Olssonofficer: Chief Commercial Officer | Sale · 2 lots | 10,000 | $26.10 | 4,733 |
| Nov 7, 2025 | James W. Mccollumdirector | Purchase | 10,500 | $22.79 | 10,500 |
| Nov 7, 2025 | Daniel R. Chevallardofficer: Chief Financial Officer | Purchase · 2 lots | 2,198 | $22.76 | 5,386 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P.10 percent owner | Sale · 6 lots | 224,974 | $46.01 | 1,814,726 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P.10 percent owner | Sale · 6 lots | 135,304 | $42.23 | 2,039,700 |
CongressHouse and Senate disclosures
Not reported.